Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Associate Professor, Department of Medicine, Yale School of Medicine; Director, Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut
Disclosure: F. Perry Wilson, MD, MSCE, has disclosed no relevant financial relationships.
Comments
Commenting is limited to medical professionals. To comment please Log-in.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
New Pandemic Peril? Pretending It's Over as Case Numbers Rise
COMMENTARY
The Case for Post-COVID Steroids
F. Perry Wilson, MD, MSCE
DisclosuresMay 12, 2022
Join the Top Medical Resource for Physicians Today. Free Membership!
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
F. Perry Wilson, MD, MSCE
Associate Professor, Department of Medicine, Yale School of Medicine; Director, Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut
Disclosure: F. Perry Wilson, MD, MSCE, has disclosed no relevant financial relationships.